“…Cholesterol-lowering drugs, called statins or 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR) inhibitors, are potent TM inducers [9,10,11]. Studies by various groups show that multiple signaling pathways (i.e., mevalonate and nitric oxide pathway) as well as numerous transcription factors (i.e., Kruppel-like transcription factors and heat shock factor 1) play an important role in statin-mediated TM induction [9,11,12,13,14].…”